New research delves into the DNA details and chromatin structures that may predict prognosis in early-stage lung ...
Janux Therapeutics' lead drug, JANX007, shows promising prostate cancer results with no serious side effects. Find out why ...
SAN ANTONIO, March 26, 2025--bioAffinity Technologies' CyPath Lung test uncovered a hidden second primary lung cancer in a patient who had been treated for lung cancer earlier.
One study showed small cell lung cancer (SCLC) tumors with higher DNA damage response (DDR) activity were initially more ...
Every year, 1.8 million people lose their lives to lung cancer, making it one of the deadliest diseases and one of the leading causes of cancer-related deaths worldwide. A major reason for the high ...
“How I Knew I Had Ovarian Cancer”: A Patient’s Story Reveals an Unexpected Benefit of Daily Exercise
A woman's story of literal strength shows how ovarian cancer can be missed—and the lighthearted recovery milestone every care ...
The cancer diagnostics market was valued at $168,600.04 million in 2020, and is projected to reach $280,590.21 million by 2028, registering a CAGR of 6.9% from 2021 to 2028. The major factor that ...
News-Medical.Net on MSN2d
New state-of-the-art cancer treatment center opens in Newport BeachUSC Norris Comprehensive Cancer Center, part of Keck Medicine of USC, has opened Keck Medicine of USC – Newport Beach ...
Merck has filed a petition with the U.S. Patent and Trademark Office to challenge seven of Halozyme’s patents. Halozyme said ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback